Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor

Neuroendocrinology

Volumn 66, Issue 3, 1997, Pages 212-220

  Barden, Nicholas ^b   Stec, Ingemar S M ^a   Montkowski, Alexandra ^a   Holsboer, Florian ^a   Reul, Johannes M H M ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Adrenal steroid receptors; Corticotropin; Corticotropin releasing hormone; Proopiomelanocortin; Transgenic mice

Indexed keywords

COMPLEMENTARY RNA; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; PROOPIOMELANOCORTIN; PROTEIN;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; CORTICOTROPIN BLOOD LEVEL; DEXAMETHASONE SUPPRESSION TEST; GENOME; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROVOCATION TEST; TRANSGENIC MOUSE;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CIRCADIAN RHYTHM; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE SYSTEM; GLUCOCORTICOIDS; MICE; MICE, TRANSGENIC; NEUROSECRETORY SYSTEMS; PITUITARY GLAND; RECEPTORS, GLUCOCORTICOID; RNA, ANTISENSE;

EID: 0030837391     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000127240     Document Type: Article

References (45)

1. Funder JW, Sheppard K: Adrenocortical steroids and the brain. Ann Rev Physiol 1987:49: 397-411.
2. De Kloet ER: Brain corticosteroid receptor balance and homeostatic control. Front Neuroen-docrinol 1991; 12:95-164.
3. Linthorst ACE, Flachskamm C, Müller-Preuss P, Holsboer F, Reul JMHM: Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: An in vivo microdialysis study. J Neurosci 1995; 15: 2920-2934.
4. Holsboer F: Neuroendocrinology of affective disorders: in Bloom FE, Kupfer DJ (eds): Psychopharmacology: The Fourth Generation of Progress. New York, Raven Press. 1995, pp 957-969.
5. Holsboer F, Barden N: Antidepressants and hypothalamic pituitary adrenocortical regulation. Endocr Rev 1996:17:187-205.
6. Antoni FA: Hypothalamic control of adreno-eorticolropin secretion: Advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev 1986;7:351-378.
7. Cascio CS, Shinsako J, Dallman MF: The su-prachiasmatic nuclei stimulale evening ACTH secretion in the rat. Brain Res 1987;423:173-178.
8. Szafarczyk A, Alonso G, Ixart G, Malaval F, Assenniacher I: Diurnal-stimulatcd and stress-induced ACTH release in rats is mediated by ventral noradrenergic bundle. Am J Physiol 1985;249:E219-E226.
9. Beaulieu S, Pelletier G, Vaudrv H, Barden N: Influence of the central nucleus of the amygdala on the content of corticotropin-releasing factor in the median eminence. Ncurocndocri-nology 1989;49:255-261.
10. Beaulieu S, De Paolo T, Cote J, Barden N: Participation of the central amygdaloid nucleus in the response of adrcnocorticotropin secretion to immobilization stress: Opposing roles of noradrenergic and domapinergic systems. Neurocndocrinology 1987;45:37-46.
11. Reul JMHM, De Kloet ER: Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985:117:2505-2512.
12. Miesfeld R, Okret S, Wikstrom A.-C, Wrange O, Gustafsson J.-A, Yamamoto KR: Characterization of a steroid hormone receptor gene and mRNA in wild-type and mutant cells. Nature 1984;312:779-781.
13. Arriza JL, Weinberger C, Cerclli G, Glaser TM, Handelin BL, Housman DE, Evans RM: Cloning of human mincralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor. Science 1987;237:268-275.
14. Evans RM, Arriza JL: A molecular framework for the actions of glucocorticoid hormones in the nervous system. Neuron 1989:2:1105-1112.
15. Funder JW: Corticosteroid receptors and the central nervous system. J Steroid Biochem Mo-lecBiol 1994:49:381-384.
16. Trapp T, Rupprecht R, Castren M, Reul JMHM, Holsboer F: Heterodimerization between mineralocorticoid and glucocorticoid receptor: A new principle of glucocorticoid action in the CNS. Neuron 1994:13:1457-1462.
17. Bradbury MJ, Akana SF, Cascio CS, Levin N, Jacobson L, Dallman MF: Regulation of basal ACTH secretion by corticosterone is mediated by both type I (MR) and type II (GR) receptors in rat brain. J Steroid Biochem Mol Biol 1991; 40:133-142.
18. Dallman MF, Levin N, Cascio CS, Akana SF, Jacobson L, Kuhn RW: Pharmacological evidence that the inhibition of diurnal adrcnocorticotropin secretion by corticosteroids is mediated via type-I corticosterone-preferring receptors. Endocrinology 1989:124:2844-2850.
19. Reul JMHM, De Kloet ER: Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis. J Steroid Biochem 1986;24:269-272.
20. Van Eekelen JAM, Jiang W, De Kloet ER, Bohn MC: Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus. J Neurosci Res 1988:21: 88-94.
21. Herman JP, Patel PD, Akil H, Watson SJ: Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol Endocrinol 1989;3:1886-1894.
22. van Steensel B, Van Binnendijk EP, Hornsby CD, Van der Voort HTM, Krozowski ZS, Dc Kloet ER, Van Driel R: Partial colocalization of glucocorticoid and mineralocorticoid receptors in discrete compartments in nuclei of rat hippocampus neurons. J Cell Sci 1996:109: 787-792.
23. Cintra A, Zoli M, Rosen L, Agnati LF, Okret S, Wikstrom AC, Gustafsson JA, Fuxe K: Mapping and computer assisted morphometry and microdensitometry of glucocorticoid receptor immunoreactive neurons and glial cells in the rat central nervous system. Neuroscience 1994; 62:843-897.
24. Pepin MC, Pothier F, Barden N: Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 1992:355:725-728.
25. Pepin MC, Barden N: Decreased glucocorticoid receptor activity following glucocorticoid receptor antisensc RNA gene fragment transfection. Mol Cell Biol 1991:11:1647-1653.
26. Stec I, Barden N, Reul JMHM, Holsboer F: Dexamethasonc nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor. J Psychiatr Res 1994:28: 1-5.
27. Reul JMHM, Stec I, Soder M, Holsboer F: Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrcnocortical system. Endocrinology 1993; 133:312-320.
28. Reul JMHM, Stec I, Wiegers GJ, Labeur MS, Linthorst ACE, Arzt E, Holboer F: Prenatal immune challenge alters the hvpothalamic-pi-luitary-adrenocortical axis in adult rats. J Clin Invest 1994:93:2600-2607.
29. Kramer CY: Extension of multiple range tests to group means with unequal number of replications. Biometrics 1956;12:307-310.
30. Pepin MC, Pothier F, Barden N: Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol Pharmacol 1993:42:991-995.
31. Ratka A, Sutanto W, Bloemers M, Dc Kloet ER: On the role of brain mincralocorticoid (type-1) and glucocorticoid (typc-11) receptors in neuroendocrine regulation. Neurocndocri-nology 1989:50:117-123.
32. Bradbury MJ, Akana SF, Dallman MF: Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: Evidence for a nonadditive effect of combined receptor occupation. Endocrinology 1994;134:1286-1296.
33. De Kloet ER, Reul JMHM: Feedback action and tonic influence of corticosteroids on brain function: A concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 1987;12:83-105.
34. Dallman MF, Akana SF, Cascio CS, Darlington DN, Jacobson L, Levin N: Regulation of ACTH secretion: variations on a theme of B. Rec Prog Horm Res 1987:43:113-173.
35. Richard D, Chapdclaine S, Deshaies Y, Pépin MC, Barden N: Energy balance and lipid metabolism in transgenic mice bearing an antisensc GCR gene construct. Am J Physiol 1993: 265:R146-R150.
36. Karanth S, Linthorst ACE, Stalla GK, Barden N, Holsboer F, Reul JMHM: Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function. Endocrinology 1997, in press.
37. Rots NY, Cools AR, De Jong J, De Kloet ER: Corticosteroid feedback resistance in rats genetically selected for increased dopamine responsiveness. J Neuroendocrinol 1995:7:153-161.
38. Rots NY, Cools AR, Oitzl MS. De Jong J, Sutanto W, De Kloet ER: Divergent prolactin and pituitary-adrenal activity in rats selectively bred for different dopamine responsiveness. Endocrinology 1996; 137:1678-1686.
39. Montkowski A, Barden N, Wotjak C, Stec I, Ganster J, Meaney M, Engelmann M, Reul JMHM, Landgraf R, Holsboer F: Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J Neuroendocrinol 1995;7:841-845.
40. Holsboer F, Von Bardeleben U, Gerken A, Stalla GK, Müller OA: Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. New Eng J Med 1984:311:1127.
41. Gold PW, Loriaux DL, Rov A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W, Avgerinos P, Paul S, Holdfield EH, Cutler GBJ, Chrousos GP: Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease: Pathophysiologic and diagnostic implications. N Engl J Med 1986:314:1329-1335.
42. Ncmeroff CB, Krishnan RR, Reed D, Leder R, Beam C, Dunnick NR: Adrenal gland enlargement in major depression. Arch Gen Psychiatry 1992;49:384-387.
43. Jasper MS, Engeland WC: Splanchnic neural activity modulates ultradian and circadian rhythms in adrenocortical secretion in awake rats. Neurocndocrinology 1994:59:97-109.
44. Körte SM, Bouws GAH, Bohus B: Central actions of corticotropin-releasing hormone (CRH) on behavioral neuroendocrine, and cardiovascular regulation: brain corticoid receptor involvement. Horm Bchav 1993;27:167-183.
45. Cole TJ, Blendv JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schütz G: Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 1995;9:1608-1621.